Morning Market Gainers

shares gained 40.19% to $7.22 after the company provided clinical update for BIND-014.

jumped 32.92% to $3.19 after the company signed strategic service agreement with Alipay.

shares climbed 31.03% to $1.90 after the company reported positive preliminary results from Phase 2a clinical trial of BIOD-531.

shares jumped 28.11% to $28.03 after AbbVie Inc.

, in cooperation with Neurocrine Biosciences, announces positive top-line results from Phase 3 study of investigational medicine elagolix.

shares gained 25.48% to $17.04 after the company reported the signing of two contracts and related effects on expected revenues.

rose 18.36% to $21.34 after the company reported an 11.5% rise in its December net sales.

climbed 14.61% to $20.94 on upbeat Q2 results.

shares surged 14.01% to $10.50 after the company received positive advice from the European Medicines Agency regarding its Phase 3 program with Pyridorin.

shares gained 13.72% to $2.57 after the company raised its Q4 EPS forecast from $(0.44) to (0.37) to $(0.31) to (0.25).

climbed 11.04% to $34.41 after the company reported the FDA approval of RYTARY ER-capsules for the treatment of parkinson's disease.

shares rose 9.84% to $9.38 following the report of additional positive data on important cardiac endpoint.

shares surged 7.47% to $85.21 after the company reported better-than-expected earnings for the fiscal second quarter and raised its forecast for the full year.

shares jumped 5.59% to $153.23 after the company raised its Q4 earnings forecast.

rose 4.46% to $107.65 after the company reported upbeat earnings for the fiscal third quarter and raised its forecast for the full year.

shares gained 2.80% to $36.37 on record holiday sales.